Clinical Trials Logo

Clinical Trial Details — Status: Unknown status

Administrative data

NCT number NCT01590368
Other study ID # UM-1015-12-U365
Secondary ID
Status Unknown status
Phase Phase 3
First received May 1, 2012
Last updated May 2, 2012
Start date June 2012
Est. completion date June 2012

Study information

Verified date May 2012
Source ConvaTec Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

It is hypothesised that the adhesion of electrodes and acceptability of the Electrocardiogram (ECG) trace is comparable between the two groups (marketed and test products) after 30 minutes (the intended period of use) of the electrodes.


Recruitment information / eligibility

Status Unknown status
Enrollment 20
Est. completion date June 2012
Est. primary completion date June 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Provide written informed consent

- Be a healthy volunteer and be over 18 years of age

- Willing to attend two scheduled visits for application and removal of the device and adverse event review

- Have healthy unbroken skin

Exclusion Criteria:

- Subjects with a history of sensitivity to any one of the components of the device being studied

- Subjects who have a history of skin related disorders to the chest.

- Subjects who are actively involved in the development, manufacturing, quality and marketing of Unomedical electrodes

- Subjects who have any other medical condition which, according to the investigator justifies exclusion from the study

- Subjects who have any current cardiac conditions that may lead to an abnormal ECG trace

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Marketed electrode
12 electrodes will be placed on the subject for an ECG reading to be taken
Modified "test" electrode
12 electrodes with modified adhesive will be placed on the subject to allow an ECG reading to be taken

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
ConvaTec Inc.

Outcome

Type Measure Description Time frame Safety issue
Primary Product Performance : Remain in place Ability to remain in place for a duration of 30 minutes (as per intended use) 30 minutes
Primary Product Performance: Perform Ability of the electrodes to perform after a duration of 30 minutes of wear (ECG tracing) as per intended use. 30 minutes
Secondary Safety: Adverse Events Safety will be evaluated by the nature and frequency of adverse events, (including condition of the skin under the electrodes using the Skin Irritation Scale (Appendix 4)) and ease of removal 2 days
Secondary Skin Rating Condition of the skin under the electrodes using the Skin Irritation Scale 2 days
See also
  Status Clinical Trial Phase
Completed NCT05483998 - A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants Phase 1
Recruiting NCT02235012 - Cognitive Biases Under Ketamine N/A
Recruiting NCT02417714 - Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
Completed NCT04418973 - Analysis of Breath Volatile Organic Compounds After Dyspnea Induced in the Healthy Subject. N/A
Completed NCT05088343 - Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects Phase 1
Not yet recruiting NCT06248801 - Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets Phase 1
Terminated NCT04068259 - Single Ascending Dose Study of PBI-4547 in Healthy Subjects Phase 1
Completed NCT03279302 - Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects Phase 1
Not yet recruiting NCT06233162 - Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets Phase 1
Recruiting NCT04159844 - Evaluation of the Stiffness and Pressure Applied on the Lower Leg by a New Compression Bandage on Healthy Subjects N/A
Completed NCT06137911 - Evaluation of Safety, Tolerability & Pharmacokinetics of JYP0061 in Healthy Adults. Phase 1
Completed NCT04849286 - Measurement of HTL0016878 in Cerebrospinal Fluid Phase 1
Not yet recruiting NCT06233227 - Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule Phase 1
Completed NCT04096157 - A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy Participants Phase 1
Completed NCT01200368 - Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants Phase 3
Recruiting NCT05805033 - Peri-Implant Soft Tissue Integration in Humans: Influence of Material N/A
Completed NCT04027803 - Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris® Phase 1
Recruiting NCT03467880 - Multicenter Study of Impulse Oscillometry in Chinese N/A
Completed NCT02903095 - Single Ascending Dose Study of TD-1439 in Healthy Subjects Phase 1
Active, not recruiting NCT02341508 - A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers Phase 1